Sale!

Ganglioside GD1b Antibody IgM Test

1,100 د.إ

-10%

The Ganglioside GD1b Antibody IgM Test is a specialized diagnostic assessment aimed at detecting the presence of IgM antibodies against the ganglioside GD1b in the blood. Gangliosides are a type of glycosphingolipid with one or more sialic acids attached to a sugar chain, and they play crucial roles in the central nervous system, including in the development and functioning of nerve cells. The presence of antibodies against ganglioside GD1b can be indicative of certain neurological conditions, such as Guillain-Barré syndrome (GBS), multifocal motor neuropathy, and other autoimmune neuropathies. These conditions often involve the immune system mistakenly attacking the body’s own nerve tissues, leading to a range of neurological symptoms.

The test is conducted by collecting a blood sample from the patient, which is then analyzed for the specific IgM antibodies targeting ganglioside GD1b. A positive result may suggest an autoimmune response affecting the nervous system, aiding healthcare providers in diagnosing and managing the patient’s condition more effectively.

In the United Arab Emirates, this test is available at DNA Labs UAE, a reputable laboratory known for its comprehensive range of diagnostic services. The cost of the Ganglioside GD1b Antibody IgM Test at DNA Labs UAE is 1100 AED. Patients seeking this test are usually referred by their healthcare provider based on their symptoms and clinical history, ensuring a targeted approach to diagnosing and treating neurological conditions associated with autoimmune responses.

Home  Sample collection service available

  • 100% accuaret DNA Results
  • Ranked as Most trusted Genetic DNA Lab
Guaranteed Safe Checkout

GANGLIOSIDE GD1b ANTIBODY IgM Test

At DNA Labs UAE, we offer the GANGLIOSIDE GD1b ANTIBODY IgM Test to diagnose autoimmune disorders like Guillain-Barr syndrome (GBS). This test detects the presence of IgM antibodies against the ganglioside GD1b in a person’s blood. Gangliosides are glycolipids found on nerve cells and play a crucial role in cell signaling and communication.

Test Details

The GANGLIOSIDE GD1b ANTIBODY IgM test is performed by taking a blood sample from the patient. The sample, which should be 2 mL (1 mL min.) serum from 1 SST, is shipped refrigerated or frozen. Overnight fasting is preferred, and a duly filled Test Send Out Consent Form is mandatory. The test is conducted using the Enzyme Immunoassay (EIA) method.

Symptoms and Diagnosis

Presence of IgM antibodies against ganglioside GD1b is associated with certain autoimmune diseases, especially Guillain-Barr syndrome (GBS). GBS is a rare neurological disorder characterized by the immune system mistakenly attacking the peripheral nerves, resulting in muscle weakness and paralysis.

The GANGLIOSIDE GD1b ANTIBODY IgM test is typically performed when GBS is suspected. It helps confirm the diagnosis by detecting the specific antibodies involved in the disease. The test results are reported as positive or negative, indicating the presence or absence of GD1b antibodies.

Test Cost

The cost of the GANGLIOSIDE GD1b ANTIBODY IgM test is AED 1100.0.

Report Delivery

The sample should be sent by the 7th of the month, and the report will be delivered after 2-3 weeks.

Pre Test Information

Before taking the test, it is recommended to fast overnight. Additionally, a duly filled Test Send Out Consent Form is mandatory.

Doctor and Test Department

The GANGLIOSIDE GD1b ANTIBODY IgM test is conducted by a neurologist in the OS department.

Importance of the Test

The GANGLIOSIDE GD1b ANTIBODY IgM test is a valuable tool in diagnosing GBS and other related autoimmune disorders. It helps healthcare professionals make informed decisions regarding treatment and management of the condition.

It is important to note that this test is just one component of the diagnostic process for GBS and other autoimmune disorders. Additional tests, such as nerve conduction studies and lumbar puncture, may be required to confirm the diagnosis.

Test Name GANGLIOSIDE GD1b ANTIBODY IgM Test
Components
Price 1100.0 AED
Sample Condition 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. Overnight fasting is preferred. Duly filled Test Send Out Consent Formis mandatory.
Report Delivery Sample by 7th of the month; Report after 2??3 weeks
Method EIA
Test type Disorders of Nervous System
Doctor Neurologist
Test Department: OS
Pre Test Information Overnight fasting is preferred. Duly filled Test Send Out Consent Formis mandatory.
Test Details

The GANGLIOSIDE GD1b ANTIBODY IgM test is a diagnostic test used to detect the presence of IgM antibodies against the ganglioside GD1b in a person’s blood. Gangliosides are a type of glycolipid found on the surface of nerve cells and are involved in cell signaling and communication.

The presence of IgM antibodies against ganglioside GD1b is associated with certain autoimmune diseases, particularly Guillain-Barr syndrome (GBS). GBS is a rare neurological disorder where the body’s immune system mistakenly attacks the peripheral nerves, leading to muscle weakness and paralysis.

The GANGLIOSIDE GD1b ANTIBODY IgM test is typically performed when GBS is suspected. It helps in confirming the diagnosis by detecting the specific antibodies involved in the disease. The test involves taking a blood sample from the patient, which is then analyzed in a laboratory to determine the presence and levels of GD1b antibodies.

The test results are reported as positive or negative, indicating the presence or absence of GD1b antibodies. A positive result suggests the likelihood of GBS or another related autoimmune disorder, while a negative result indicates the absence of these antibodies.

It is important to note that this test is just one component of the diagnostic process for GBS and other autoimmune disorders. Additional tests, such as nerve conduction studies and lumbar puncture, may be required to confirm the diagnosis.

Overall, the GANGLIOSIDE GD1b ANTIBODY IgM test is a valuable tool in diagnosing GBS and other related autoimmune disorders. It helps healthcare professionals make informed decisions regarding treatment and management of the condition.